Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel ...

Highlights: Dolphin Area – continued infill drilling demonstrates potential for higher grade within the main resource area ...

CNW/ - Denison Mines Corp. ("Denison" or the "Company") (TSX: DML) (NYSE American: DNN) today filed its Audited Consolidated ...

VANCOUVER, British Columbia, March 17th, 2026, FinanceWireWest Red Lake Gold Mines Ltd.(“West Red Lake Gold” or “WRLG” or ...

TORONTO, March 10, 2026 /CNW/ - Denison Mines Corp. ("Denison" or the "Company") (TSX: DML) (NYSE American: DNN) today filed its Audited Consolidated Financial Statements and Management's Discussion & ...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...

Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC - - Combin ...

Newcore Gold Ltd. is pleased to announce that on the back of the success achieved to date with drilling at the Company’s ...

Nuvation Bio Inc. (NYSE:NUVB) Q4 2025 Earnings Call Transcript March 3, 2026 Operator: Hello, and welcome to Nuvation Bio’s Fourth Quarter and Full Year 2020 Financial Results and Corporate Update ...

Leerink Global Healthcare Conference 2026 March 10, 2026 10:40 AM EDTCompany ParticipantsAndrew Peters - Senior Vice President ...

Earnings call Legend Biotech posted 64% year-over-year revenue growth in Q4 2025, propelled by CARVYKTI’s expanding market share and manufacturing scale. Gross margin stabilized at 61%, and the ...